Fig. 2From: Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancerKaplan-Meier curves for (a) locoregional control, (b) progression-free survival, and (c) overall survival in patients receiving weekly carboplatin versus every-3-weeks cisplatin chemoradiation regimens. The log rank test was used to assess for differences in outcomesBack to article page